In a journal article published in Diabetes Technology & Therapeutics, first author Morgan Jones, MD, assistant professor of medicine in the division of endocrinology and metabolism, said transitioning to virtual care models does not limit the glycemic outcomes of inpatient diabetes care.
Telehealth visits for patients with diabetes appear to show positive results, according to a study published in the journal Diabetes Technology & Therapeutics.
After collecting data at UNC Medical Center before and after the beginning of the COVID-19 pandemic, the study investigators found that transitioning to virtual care did not limit glycemic outcomes of inpatient diabetes care. In an effort to reduce PPE use and decrease potential exposures between provider and patient, the forms of telehealth included a phone call interview to the patient (or family member if patient was unavailable or primary nurse) each morning by an endocrinologist. Reports included finger stick blood glucose (FSBG) or serum blood glucose tests less than 70 mg/dL or greater than 180 mg/dL. The proportion of FSBG results varied from week to week before and after implementing virtual care but overall showed fair consistency.
Learn more from the UNC Health and UNC School of Medicine Newsroom.